510(k) Report

FDA applicant

Medeon Biodesign, Inc.

Taipei, TW7 decisions2015–20200 recalls

FDA records 7 decisions for Medeon Biodesign, Inc. (Taipei, TW) from 2015 to 2020: 7 510(k) clearances. Most are in product codes GCJ (Laparoscope, General & Plastic Surgery) and OCW (Endoscopic Tissue Approximation Device). Since 2016 its 510(k)s took a median of 32 days from receipt to decision, against 69 for FDA’s reviews in the same codes and years. Its devices cite 7 predicates, 5 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, gastroenterology and urology panel, where it files most

How often FDA has decided Medeon Biodesign, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2020

2015: 12016: 22017: 12019: 12020: 2
2015high 2 (2016) · low 0 (2018)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2015.

FIG. 1 — Medeon Biodesign, Inc. by year, 2015–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Medeon Biodesign, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report